TLDR
- UnitedHealth delivered Q1 adjusted earnings of $7.23 per share, surpassing the anticipated $6.58, while revenues reached $111.7 billion versus $109.4 billion projected.
- Shares surged 5.7% to reach $342 during Tuesday’s premarket session.
- Annual adjusted EPS forecast increased to above $18.25, representing an upgrade from the $17.75 January projection.
- Medical care ratio enhanced to 83.9% in Q1 2026, declining from the prior year’s 84.8%.
- The company commits minimum $1.5 billion toward AI initiatives to counter a $6 billion Medicare payment challenge.
UnitedHealth Group delivered impressive first-quarter performance, surpassing analyst projections for both profits and revenues while simultaneously boosting its annual forecast. These outcomes emerge as the healthcare giant advances its restructuring initiatives under CEO Stephen Hemsley, who resumed leadership last May.
First-quarter adjusted profits registered $7.23 per share, significantly exceeding the analyst consensus of $6.58. Revenues totaled $111.7 billion, surpassing expectations of $109.4 billion. The quarter’s net profit reached $6.28 billion, translating to $6.90 per share.
Shares experienced a 5.7% surge to $342 during Tuesday’s premarket activity.
UnitedHealth Group Incorporated, UNH
The annual adjusted EPS projection was elevated to exceed $18.25, representing an increase from the $17.75 forecast issued in January. CFO Wayne DeVeydt informed Barron’s that management would probably wait until post-Q2 results before contemplating additional adjustments. “We’d prefer to accumulate several additional months of data,” he explained.
UnitedHealthcare’s revenues expanded to $86.3 billion during the quarter, compared to $84.6 billion in Q1 2025. The operating margin registered 6.6%, advancing from 6.2% recorded a year earlier.
Medical Expense Metrics Display Progress
Among the report’s most encouraging indicators was the medical care ratio — representing premium revenue allocated to medical expenses. This metric decreased to 83.9% in Q1 2026 from 84.8% during Q1 2025. This represents substantial progress following the ratio’s climb to 91.5% in Q4 2025.
Management credited the enhancement to effective cost controls and positive reserve adjustments. However, increased utilization rates and rising unit costs partially counterbalanced these improvements.
UnitedHealth has been strategically withdrawing from unprofitable segments, including specific individual ACA offerings and select Medicare Advantage regions. This resulted in membership declining from 49.8 million at 2025’s conclusion to 49.1 million in Q1 2026. Medicare Advantage participation decreased by 965,000 members during the period.
Optum Division and Artificial Intelligence Spending
Optum Health, which faced challenges throughout 2025, generated $1.3 billion in adjusted operational earnings for Q1. DeVeydt characterized it as a “highly promising beginning” relative to annual projections exceeding $1.6 billion. “We perceive this as an extended transformation,” he noted.
UnitedHealth is allocating a minimum of $1.5 billion toward artificial intelligence technologies this year. Management indicates these investments are instrumental in addressing a $6 billion challenge stemming from previous Medicare payment modifications. DeVeydt emphasized the AI projects deliver returns in a “remarkably brief” timeframe.
Earlier this month, Medicare administrators validated an average 2.48% payment elevation for insurers effective next year. UNH stock had already appreciated 9% following that announcement. DeVeydt recognized the increase “fell short of completely offsetting” prevailing medical cost trends, and that benefit reductions remain necessary for 2026.
Morgan Stanley elevated UNH to “top pick” status on April 16, pointing to anticipation of “consecutive solid quarters” following the more advantageous Medicare rate disclosure.
UnitedHealthcare’s employer-sponsored self-funded operations compensated for portions of the membership decline, while the insurer’s OptumRx pharmacy benefit division also bolstered overall revenue expansion.


